167 related articles for article (PubMed ID: 20507178)
1. Structural analysis of botulinum neurotoxin type G receptor binding .
Schmitt J; Karalewitz A; Benefield DA; Mushrush DJ; Pruitt RN; Spiller BW; Barbieri JT; Lacy DB
Biochemistry; 2010 Jun; 49(25):5200-5. PubMed ID: 20507178
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
Stenmark P; Dong M; Dupuy J; Chapman ER; Stevens RC
J Mol Biol; 2010 Apr; 397(5):1287-97. PubMed ID: 20219474
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
Chai Q; Arndt JW; Dong M; Tepp WH; Johnson EA; Chapman ER; Stevens RC
Nature; 2006 Dec; 444(7122):1096-100. PubMed ID: 17167418
[TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
Peng L; Berntsson RP; Tepp WH; Pitkin RM; Johnson EA; Stenmark P; Dong M
J Cell Sci; 2012 Jul; 125(Pt 13):3233-42. PubMed ID: 22454523
[TBL] [Abstract][Full Text] [Related]
5. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E.
Masuyer G; Davies JR; Stenmark P
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361086
[TBL] [Abstract][Full Text] [Related]
8. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
Rummel A
Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
Dong M; Tepp WH; Liu H; Johnson EA; Chapman ER
J Cell Biol; 2007 Dec; 179(7):1511-22. PubMed ID: 18158333
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.
Willjes G; Mahrhold S; Strotmeier J; Eichner T; Rummel A; Binz T
Biochemistry; 2013 Jun; 52(22):3930-8. PubMed ID: 23647335
[TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
[TBL] [Abstract][Full Text] [Related]
12. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.
Kroken AR; Karalewitz AP; Fu Z; Kim JJ; Barbieri JT
J Biol Chem; 2011 Jul; 286(30):26828-37. PubMed ID: 21632541
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
Jin R; Rummel A; Binz T; Brunger AT
Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
[TBL] [Abstract][Full Text] [Related]
15. Synaptotagmin Binding to Botulinum Neurotoxins.
Martínez-Carranza M; Blasco P; Gustafsson R; Dong M; Berntsson RP; Widmalm G; Stenmark P
Biochemistry; 2020 Feb; 59(4):491-498. PubMed ID: 31809018
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.
Berntsson RP; Peng L; Svensson LM; Dong M; Stenmark P
Structure; 2013 Sep; 21(9):1602-11. PubMed ID: 23932591
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.
Swaminathan S; Eswaramoorthy S
Nat Struct Biol; 2000 Aug; 7(8):693-9. PubMed ID: 10932256
[TBL] [Abstract][Full Text] [Related]
18. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
Peng L; Tepp WH; Johnson EA; Dong M
PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
[TBL] [Abstract][Full Text] [Related]
19. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
Atassi MZ; Taruishi M; Naqvi M; Steward LE; Aoki KR
Protein J; 2014 Jun; 33(3):278-88. PubMed ID: 24740609
[TBL] [Abstract][Full Text] [Related]
20. Unique ganglioside binding by botulinum neurotoxins C and D-SA.
Kroken AR; Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
FEBS J; 2011 Dec; 278(23):4486-96. PubMed ID: 21554541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]